{"gene":"MLF2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1996,"finding":"MLF2 encodes a 248-amino-acid protein highly related to MLF1 (63% similarity, 40% identity) and is ubiquitously expressed; its gene locus was mapped to human chromosome 12p13 by fluorescence in situ hybridization.","method":"cDNA cloning, FISH, Southern blotting","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct cloning and chromosomal mapping with multiple orthogonal methods (sequencing, FISH, Southern blot)","pmids":["8661158"],"is_preprint":false},{"year":2017,"finding":"MLF2 co-aggregates with poly-GA inclusions (from C9orf72 repeat expansion) along with p62 and Rad23b in both transgenic mouse spinal cord and ALS/FTD patient samples, indicating MLF2 is sequestered by poly-GA aggregates.","method":"Immunofluorescence co-localization in transgenic mouse model and patient tissue","journal":"Acta neuropathologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-localization confirmed in two independent systems (mouse model and patient samples), but no in vitro binding reconstitution","pmids":["28409281"],"is_preprint":false},{"year":2016,"finding":"MLF2 preferentially interacts with mutant (polyQ-expanded) N-terminal huntingtin over wild-type HTT, reduces the number of cells containing mutant HTT aggregates, increases the mobile fraction of mutant HTT aggregates in FRAP assays, and reduces mutant HTT-induced apoptosis in Neuro2A cells.","method":"Co-immunoprecipitation, FRAP, cell viability assay in Neuro2A cells","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, FRAP, apoptosis assay) in a single lab study","pmids":["27840155"],"is_preprint":false},{"year":2014,"finding":"shRNA knockdown of MLF2 in breast cancer patient-derived xenografts reduced tumor volume, lung metastases, and breast cancer stem cell self-renewal; MLF2 affects the nitric oxide synthase pathway and its expression is altered by hypoxia.","method":"shRNA knockdown, siRNA nanoparticle delivery in patient-derived xenografts, RNA deep sequencing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular and in vivo phenotype, pathway identification by RNA-seq, single lab","pmids":["24876273"],"is_preprint":false},{"year":2020,"finding":"MLF2 is a luminal component of nuclear envelope blebs that form upon Torsin ATPase manipulation; bleb formation requires POM121 (a transmembrane nucleoporin essential for interphase NPC biogenesis), occurs rapidly after nuclear envelope reformation during mitosis, and is independent of ubiquitin conjugation within the bleb. Torsin-deficient cells show reduction of mature NPCs, establishing that blebs represent aberrant NPC intermediates.","method":"Proteomics, live-cell imaging with MLF2-based platform, immunofluorescence, genetic depletion of POM121","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — proteomics identification, live-cell imaging platform, genetic epistasis with POM121, multiple orthogonal methods in one rigorous study","pmids":["32342107"],"is_preprint":false},{"year":2020,"finding":"DCAF8 (part of the CRL4DCAF8 E3 ligase complex) strongly interacts with MLF2 and promotes its degradation through the ubiquitin-proteasome pathway; conversely, the deubiquitinase USP11 associates with MLF2 and increases its stability.","method":"Co-immunoprecipitation, proteasome inhibitor assays, overexpression and knockdown","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP for both E3 ligase and DUB interactions, proteasome pathway confirmed, single lab","pmids":["32703400"],"is_preprint":false},{"year":2022,"finding":"MLF2 in nuclear envelope blebs suppresses ectopic accumulation of FG-nucleoporins and modulates the selective properties and size of FG-nucleoporin condensates in vitro; MLF2 also modulates a selective HSP40-HSP70 chaperone network that is sequestered into blebs, contributing to proteotoxicity in DYT1 dystonia.","method":"In vitro condensate reconstitution assay, live-cell imaging, co-immunoprecipitation, genetic manipulation of TorsinA","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution of condensate modulation, live-cell imaging, chaperone network identification with multiple orthogonal methods","pmids":["36302970"],"is_preprint":false},{"year":2019,"finding":"MLF2 is phosphorylated at serine 24 (detected by Phos-tag SDS-PAGE), and this phosphorylation is required for MLF2 oncogenic activity in CML; point mutation at Ser24 abolishes the effects of MLF2 overexpression on colony formation in vitro and mouse survival in vivo.","method":"Phos-tag SDS-PAGE, site-directed mutagenesis, colony formation assay, mouse xenograft survival","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — phosphorylation confirmed biochemically plus mutagenesis with functional rescue in vitro and in vivo, single lab","pmids":["31831854"],"is_preprint":false},{"year":2023,"finding":"MLF2 interacts with both p53 and USP7; via these interactions, MLF2 inhibits USP7 binding to p53 and antagonizes USP7-mediated deubiquitination of p53, leading to p53 destabilization and promoting colorectal carcinogenesis.","method":"Co-immunoprecipitation, ubiquitination assay, loss-of-function experiments, in vivo tumor models","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for both partners, deubiquitination assay establishing mechanism, functional rescue, single lab","pmids":["37438558"],"is_preprint":false},{"year":2025,"finding":"PIM3 kinase phosphorylates MLF2 at Ser65, which enhances MLF2 stabilization through interaction with the deubiquitinase USP21; independently, the E3 ligase STUB1 ubiquitinates MLF2 at Lys119 and targets it for proteasomal degradation. MLF2 promotes osteosarcoma metastasis by disrupting the interaction between BiP and IRE1α, thereby activating the IRE1α/XBP1-S-MMP9 axis.","method":"In vivo CRISPR activation screen, interactome (STUB1 pulldown), co-immunoprecipitation, kinase assay, ubiquitination assay, site-directed mutagenesis, in vivo metastasis models","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods: CRISPR screen, interactome, Co-IP, kinase/ubiquitination assays, mutagenesis, and in vivo validation","pmids":["41090348"],"is_preprint":false},{"year":2025,"finding":"MLF2 acts as a chaperone that promotes SWI/SNF (BAF) complex assembly and binding to chromatin; rapid degradation of MLF2 reduces chromatin accessibility at sites dependent on high SWI/SNF occupancy.","method":"CRISPR KO screen with epigenome editing, rapid protein degradation (degron), ATAC-seq for chromatin accessibility, ChIP-seq","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — CRISPR screen, acute degron depletion with orthogonal chromatin accessibility and SWI/SNF occupancy readouts, multiple methods","pmids":["40447637"],"is_preprint":false},{"year":2025,"finding":"MLF2 interacts with αB-crystallin (CryAB) in cardiomyocytes; MLF2 is upregulated in mouse heart failure models and hypertrophic cardiomyocytes, and its overexpression attenuates pro-hypertrophic gene expression.","method":"Protein interaction (pulldown/Co-IP), immunofluorescence in mouse DRM models, cardiomyocyte overexpression with gene expression analysis","journal":"Journal of cardiovascular development and disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP/pulldown for CryAB interaction, overexpression phenotype without pathway placement, single lab with limited mechanistic detail in abstract","pmids":["41590846"],"is_preprint":false},{"year":2025,"finding":"MLF2 functions as a versatile condensate biomarker for nuclear envelope blebs in DYT1 dystonia; a genome-wide CRISPR/Cas9 screen using MLF2-based condensate readout linked condensate accumulation to microcephaly gene ZNF335 (nucleoplasmic condensates) and RNF26 deletion (nuclear envelope condensates phenocopying torsin deficiency).","method":"High-content imaging screen with MLF2 as condensate reporter, genome-wide CRISPR/Cas9 screen, machine learning condensate phenotyping","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide genetic screen with imaging readout using MLF2 as validated reporter, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.06.07.658469"],"is_preprint":true}],"current_model":"MLF2 is a ubiquitously expressed chaperone-like protein that functions at the nuclear envelope to modulate nuclear pore complex biogenesis (as a luminal bleb component dependent on POM121), suppresses FG-nucleoporin condensate formation and modulates HSP40-HSP70 chaperone networks, promotes SWI/SNF chromatin remodeling complex assembly, and is regulated post-translationally by competing ubiquitination (STUB1 at Lys119, CRL4DCAF8) and deubiquitination (USP11, USP21) as well as by phosphorylation (PIM3 at Ser65, at Ser24 in CML); in cancer contexts MLF2 destabilizes p53 by antagonizing USP7-mediated deubiquitination, activates the IRE1α/XBP1-S-MMP9 axis to promote metastasis, and affects nitric oxide synthase signaling in breast cancer stem cells."},"narrative":{"mechanistic_narrative":"MLF2 is a ubiquitously expressed chaperone-like protein that operates at the nuclear envelope and within chromatin to regulate protein and nucleoporin homeostasis, and that is co-opted in multiple cancers [PMID:8661158, PMID:32342107, PMID:40447637]. At the nuclear envelope, MLF2 is a luminal component of aberrant nuclear envelope blebs that form upon Torsin ATPase manipulation; bleb biogenesis requires the transmembrane nucleoporin POM121 and occurs as cells reassemble nuclear pore complexes after mitosis, marking blebs as defective NPC intermediates [PMID:32342107]. Within these blebs MLF2 suppresses ectopic FG-nucleoporin accumulation, modulates the selective properties and size of FG-nucleoporin condensates in vitro, and tunes a sequestered HSP40-HSP70 chaperone network that drives proteotoxicity in DYT1 dystonia [PMID:36302970]. Beyond the envelope, MLF2 acts as a chaperone promoting SWI/SNF (BAF) complex assembly and chromatin binding, such that its acute depletion reduces chromatin accessibility at SWI/SNF-dependent sites [PMID:40447637]. MLF2 protein levels are set by competing ubiquitination and deubiquitination: the CRL4-DCAF8 E3 ligase and STUB1 (ubiquitinating Lys119) drive proteasomal degradation, while USP11 and USP21 stabilize the protein, and PIM3-mediated phosphorylation at Ser65 promotes stabilization through USP21 [PMID:32703400, PMID:41090348]. In cancer, MLF2 destabilizes p53 by blocking USP7-mediated deubiquitination to drive colorectal carcinogenesis [PMID:37438558], promotes osteosarcoma metastasis by disrupting the BiP-IRE1α interaction to activate the IRE1α/XBP1-S-MMP9 axis [PMID:41090348], and requires Ser24 phosphorylation for its oncogenic activity in CML [PMID:31831854]. Consistent with its chaperone-like role in protein aggregation, MLF2 is sequestered into poly-GA inclusions in C9orf72 ALS/FTD and preferentially engages mutant polyQ huntingtin, where it increases aggregate mobility and reduces aggregate-induced apoptosis [PMID:28409281, PMID:27840155].","teleology":[{"year":1996,"claim":"Established MLF2 as a gene and protein in its own right, a ubiquitously expressed homolog of MLF1, defining the molecular entity before any function was known.","evidence":"cDNA cloning, FISH chromosomal mapping, and Southern blotting","pmids":["8661158"],"confidence":"High","gaps":["No biochemical activity or interaction partner defined","No subcellular localization established","Functional role entirely unknown at this stage"]},{"year":2014,"claim":"First functional implication: MLF2 supports breast cancer growth, metastasis, and cancer stem cell self-renewal, linking it to nitric oxide synthase signaling and hypoxia.","evidence":"shRNA/siRNA knockdown in patient-derived xenografts with RNA deep sequencing","pmids":["24876273"],"confidence":"Medium","gaps":["No direct molecular mechanism connecting MLF2 to the NOS pathway","No physical partners identified","Phenotype correlative rather than mechanistic"]},{"year":2017,"claim":"Implicated MLF2 in neurodegenerative aggregate biology by showing it is sequestered into pathological protein inclusions, hinting at a chaperone-like or aggregate-engaging activity.","evidence":"Co-IP, FRAP and viability assays with polyQ huntingtin in Neuro2A cells; immunofluorescence co-localization with poly-GA inclusions in mouse and ALS/FTD patient tissue","pmids":["27840155","28409281"],"confidence":"Medium","gaps":["No reconstituted binding to demonstrate direct interaction with aggregating species","Mechanism of preferential mutant-HTT engagement undefined","Sequestration into poly-GA shown only by co-localization"]},{"year":2020,"claim":"Defined MLF2 as a luminal nuclear-envelope-bleb component dependent on POM121, recasting blebs as aberrant NPC biogenesis intermediates and giving MLF2 a concrete nuclear-envelope role.","evidence":"Proteomics, live-cell imaging with an MLF2-based platform, immunofluorescence, and POM121 genetic depletion","pmids":["32342107"],"confidence":"High","gaps":["Molecular activity of MLF2 within the bleb not yet defined","How MLF2 is recruited to the luminal space unknown","Functional consequence for mature NPCs not directly tied to MLF2"]},{"year":2020,"claim":"Showed MLF2 abundance is post-translationally controlled by opposing ubiquitin machinery, identifying CRL4-DCAF8 as a destabilizer and USP11 as a stabilizer.","evidence":"Reciprocal Co-IP, proteasome inhibitor assays, and overexpression/knockdown","pmids":["32703400"],"confidence":"Medium","gaps":["Ubiquitination site not mapped in this study","No physiological trigger for degradation defined","Single-lab finding"]},{"year":2022,"claim":"Assigned a biochemical function to MLF2 at the envelope: suppression of FG-nucleoporin condensate accumulation and modulation of a bleb-sequestered HSP40-HSP70 chaperone network underlying DYT1 dystonia proteotoxicity.","evidence":"In vitro condensate reconstitution, live-cell imaging, Co-IP, and TorsinA genetic manipulation","pmids":["36302970"],"confidence":"High","gaps":["Direct binding determinants for FG-nucleoporins not mapped","Which HSP40/HSP70 members are engaged and how is incomplete","Stoichiometry and structural basis of condensate modulation unknown"]},{"year":2019,"claim":"Identified phosphorylation at Ser24 as functionally required for MLF2 oncogenic activity in CML, linking a post-translational mark to transforming function.","evidence":"Phos-tag SDS-PAGE, Ser24 mutagenesis, colony formation, and mouse xenograft survival","pmids":["31831854"],"confidence":"Medium","gaps":["Kinase responsible for Ser24 phosphorylation not identified","Downstream effectors of phospho-MLF2 in CML undefined","Single-lab study"]},{"year":2023,"claim":"Established a tumor-promoting mechanism: MLF2 destabilizes p53 by competing with USP7, blocking p53 deubiquitination to drive colorectal carcinogenesis.","evidence":"Co-IP with p53 and USP7, ubiquitination assay, loss-of-function, and in vivo tumor models","pmids":["37438558"],"confidence":"Medium","gaps":["Structural basis of MLF2-USP7 competition unresolved","Whether this axis operates in other tumor types untested here","Single-lab finding"]},{"year":2025,"claim":"Integrated MLF2 regulation and a metastasis mechanism: PIM3-Ser65 phosphorylation stabilizes MLF2 via USP21 while STUB1 ubiquitinates Lys119 for degradation, and MLF2 disrupts BiP-IRE1α to activate the IRE1α/XBP1-S-MMP9 axis driving osteosarcoma metastasis.","evidence":"In vivo CRISPR activation screen, interactome, Co-IP, kinase and ubiquitination assays, site-directed mutagenesis, and in vivo metastasis models","pmids":["41090348"],"confidence":"High","gaps":["How phosphorylation at Ser65 mechanistically favors USP21 over STUB1 unclear","Direct binding interface with BiP/IRE1α not structurally defined","Whether the same regulatory logic applies outside osteosarcoma untested"]},{"year":2025,"claim":"Revealed a chromatin function: MLF2 acts as a chaperone promoting SWI/SNF (BAF) complex assembly and chromatin engagement, with acute loss reducing accessibility at SWI/SNF-dependent sites.","evidence":"CRISPR KO screen with epigenome editing, degron-based rapid depletion, ATAC-seq, and ChIP-seq","pmids":["40447637"],"confidence":"High","gaps":["Which BAF subunits MLF2 directly chaperones not specified","Whether nuclear-envelope and chromatin roles are mechanistically linked unknown","Structural basis of chaperone activity undefined"]},{"year":2025,"claim":"Extended MLF2 condensate biology by using it as a genome-wide screening reporter, linking nuclear envelope and nucleoplasmic condensate accumulation to ZNF335 and RNF26.","evidence":"High-content imaging genome-wide CRISPR/Cas9 screen with MLF2 condensate reporter and machine-learning phenotyping (preprint)","pmids":["bio_10.1101_2025.06.07.658469"],"confidence":"Medium","gaps":["Not yet peer-reviewed","Mechanistic role of ZNF335/RNF26 relative to MLF2 not established","MLF2's own activity in these condensates not directly tested here"]},{"year":2025,"claim":"Suggested a cardiac role through interaction with αB-crystallin and an anti-hypertrophic effect on cardiomyocyte gene expression.","evidence":"Pulldown/Co-IP for CryAB, immunofluorescence in mouse DRM models, cardiomyocyte overexpression","pmids":["41590846"],"confidence":"Low","gaps":["Single Co-IP/pulldown without reciprocal or structural validation","No pathway placement for the anti-hypertrophic effect","Causality versus correlation in heart failure models unresolved"]},{"year":null,"claim":"Whether MLF2's distinct activities — nuclear-envelope condensate modulation, SWI/SNF chaperoning, and oncogenic ubiquitin/IRE1α signaling — reflect a single unifying chaperone-like biochemical mechanism remains unresolved.","evidence":"No single study reconciles the nuclear-envelope, chromatin, and cancer-signaling roles into one molecular activity","pmids":[],"confidence":"Low","gaps":["No structure of MLF2 or its complexes","Core biochemical activity not defined","Tissue-specific selection among partners unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[6,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,8,9]}],"localization":[{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[4,6]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[4]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[5,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,8,9]}],"complexes":["nuclear envelope bleb (aberrant NPC intermediate)","SWI/SNF (BAF) complex (assembly chaperone)"],"partners":["POM121","USP11","DCAF8","USP7","STUB1","USP21","PIM3","CRYAB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15773","full_name":"Myeloid leukemia factor 2","aliases":["Myelodysplasia-myeloid leukemia factor 2"],"length_aa":248,"mass_kda":28.1,"function":"","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15773/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MLF2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MLF2","total_profiled":1310},"omim":[{"mim_id":"601402","title":"MYELOID LEUKEMIA FACTOR 1; MLF1","url":"https://www.omim.org/entry/601402"},{"mim_id":"601401","title":"MYELOID LEUKEMIA FACTOR 2; MLF2","url":"https://www.omim.org/entry/601401"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MLF2"},"hgnc":{"alias_symbol":["NTN4"],"prev_symbol":[]},"alphafold":{"accession":"Q15773","domains":[{"cath_id":"-","chopping":"99-203","consensus_level":"medium","plddt":88.6663,"start":99,"end":203}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15773","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15773-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15773-F1-predicted_aligned_error_v6.png","plddt_mean":65.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MLF2","jax_strain_url":"https://www.jax.org/strain/search?query=MLF2"},"sequence":{"accession":"Q15773","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15773.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15773/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15773"}},"corpus_meta":[{"pmid":"28409281","id":"PMC_28409281","title":"Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss.","date":"2017","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/28409281","citation_count":99,"is_preprint":false},{"pmid":"24876273","id":"PMC_24876273","title":"Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24876273","citation_count":94,"is_preprint":false},{"pmid":"21325289","id":"PMC_21325289","title":"Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/21325289","citation_count":92,"is_preprint":false},{"pmid":"32342107","id":"PMC_32342107","title":"Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2.","date":"2020","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32342107","citation_count":55,"is_preprint":false},{"pmid":"36302970","id":"PMC_36302970","title":"Atypical nuclear envelope condensates linked to neurological disorders reveal nucleoporin-directed chaperone activities.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36302970","citation_count":42,"is_preprint":false},{"pmid":"8661158","id":"PMC_8661158","title":"cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia/myeloid leukemia factor 2 (MLF2).","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661158","citation_count":30,"is_preprint":false},{"pmid":"31388936","id":"PMC_31388936","title":"Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.","date":"2019","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/31388936","citation_count":17,"is_preprint":false},{"pmid":"32703400","id":"PMC_32703400","title":"CRL4DCAF8 and USP11 oppositely regulate the stability of myeloid leukemia factors (MLFs).","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32703400","citation_count":13,"is_preprint":false},{"pmid":"37438558","id":"PMC_37438558","title":"MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37438558","citation_count":12,"is_preprint":false},{"pmid":"27840155","id":"PMC_27840155","title":"Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27840155","citation_count":11,"is_preprint":false},{"pmid":"40229327","id":"PMC_40229327","title":"Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancer.","date":"2025","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40229327","citation_count":9,"is_preprint":false},{"pmid":"31831854","id":"PMC_31831854","title":"The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis.","date":"2019","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31831854","citation_count":8,"is_preprint":false},{"pmid":"20008798","id":"PMC_20008798","title":"Genetic effects analysis of myeloid leukemia factor 2 and T cell receptor-beta on resistance to coccidiosis in chickens.","date":"2010","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/20008798","citation_count":7,"is_preprint":false},{"pmid":"40447637","id":"PMC_40447637","title":"CRISPR screen decodes SWI/SNF chromatin remodeling complex assembly.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40447637","citation_count":6,"is_preprint":false},{"pmid":"34557292","id":"PMC_34557292","title":"Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia.","date":"2021","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/34557292","citation_count":6,"is_preprint":false},{"pmid":"9829833","id":"PMC_9829833","title":"Growth inhibition of Saccharomyces cerevisiae by the immunosuppressant leflunomide is due to the inhibition of uracil uptake via Fur4p.","date":"1998","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/9829833","citation_count":6,"is_preprint":false},{"pmid":"20633251","id":"PMC_20633251","title":"Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.","date":"2010","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/20633251","citation_count":4,"is_preprint":false},{"pmid":"37095576","id":"PMC_37095576","title":"A myeloid leukemia factor homolog is involved in tolerance to stresses and stress-induced protein metabolism in Giardia lamblia.","date":"2023","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/37095576","citation_count":3,"is_preprint":false},{"pmid":"21645301","id":"PMC_21645301","title":"Identification of parental line specific effects of MLF2 on resistance to coccidiosis in chickens.","date":"2011","source":"BMC proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/21645301","citation_count":1,"is_preprint":false},{"pmid":"41090348","id":"PMC_41090348","title":"PIM3-mediated phosphorylation stabilizes myeloid leukemia factor 2 to promote metastasis in osteosarcoma.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/41090348","citation_count":0,"is_preprint":false},{"pmid":"41590846","id":"PMC_41590846","title":"First Glance at Myeloid Leukaemia Factor 2 in Cardiomyocytes.","date":"2025","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/41590846","citation_count":0,"is_preprint":false},{"pmid":"40313973","id":"PMC_40313973","title":"Correction to \"NAC4ED: A high-throughput computational platform for the rational design of enzyme activity and substrate selectivity\".","date":"2025","source":"mLife","url":"https://pubmed.ncbi.nlm.nih.gov/40313973","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.07.658469","title":"Integrative Chemical Genetics Platform Identifies Condensate Modulators Linked to Neurological Disorders","date":"2025-06-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.07.658469","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11762,"output_tokens":3214,"usd":0.041748,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10739,"output_tokens":4528,"usd":0.083447,"stage2_stop_reason":"end_turn"},"total_usd":0.125195,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MLF2 encodes a 248-amino-acid protein highly related to MLF1 (63% similarity, 40% identity) and is ubiquitously expressed; its gene locus was mapped to human chromosome 12p13 by fluorescence in situ hybridization.\",\n      \"method\": \"cDNA cloning, FISH, Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct cloning and chromosomal mapping with multiple orthogonal methods (sequencing, FISH, Southern blot)\",\n      \"pmids\": [\"8661158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MLF2 co-aggregates with poly-GA inclusions (from C9orf72 repeat expansion) along with p62 and Rad23b in both transgenic mouse spinal cord and ALS/FTD patient samples, indicating MLF2 is sequestered by poly-GA aggregates.\",\n      \"method\": \"Immunofluorescence co-localization in transgenic mouse model and patient tissue\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-localization confirmed in two independent systems (mouse model and patient samples), but no in vitro binding reconstitution\",\n      \"pmids\": [\"28409281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MLF2 preferentially interacts with mutant (polyQ-expanded) N-terminal huntingtin over wild-type HTT, reduces the number of cells containing mutant HTT aggregates, increases the mobile fraction of mutant HTT aggregates in FRAP assays, and reduces mutant HTT-induced apoptosis in Neuro2A cells.\",\n      \"method\": \"Co-immunoprecipitation, FRAP, cell viability assay in Neuro2A cells\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, FRAP, apoptosis assay) in a single lab study\",\n      \"pmids\": [\"27840155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"shRNA knockdown of MLF2 in breast cancer patient-derived xenografts reduced tumor volume, lung metastases, and breast cancer stem cell self-renewal; MLF2 affects the nitric oxide synthase pathway and its expression is altered by hypoxia.\",\n      \"method\": \"shRNA knockdown, siRNA nanoparticle delivery in patient-derived xenografts, RNA deep sequencing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular and in vivo phenotype, pathway identification by RNA-seq, single lab\",\n      \"pmids\": [\"24876273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MLF2 is a luminal component of nuclear envelope blebs that form upon Torsin ATPase manipulation; bleb formation requires POM121 (a transmembrane nucleoporin essential for interphase NPC biogenesis), occurs rapidly after nuclear envelope reformation during mitosis, and is independent of ubiquitin conjugation within the bleb. Torsin-deficient cells show reduction of mature NPCs, establishing that blebs represent aberrant NPC intermediates.\",\n      \"method\": \"Proteomics, live-cell imaging with MLF2-based platform, immunofluorescence, genetic depletion of POM121\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — proteomics identification, live-cell imaging platform, genetic epistasis with POM121, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"32342107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DCAF8 (part of the CRL4DCAF8 E3 ligase complex) strongly interacts with MLF2 and promotes its degradation through the ubiquitin-proteasome pathway; conversely, the deubiquitinase USP11 associates with MLF2 and increases its stability.\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor assays, overexpression and knockdown\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP for both E3 ligase and DUB interactions, proteasome pathway confirmed, single lab\",\n      \"pmids\": [\"32703400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MLF2 in nuclear envelope blebs suppresses ectopic accumulation of FG-nucleoporins and modulates the selective properties and size of FG-nucleoporin condensates in vitro; MLF2 also modulates a selective HSP40-HSP70 chaperone network that is sequestered into blebs, contributing to proteotoxicity in DYT1 dystonia.\",\n      \"method\": \"In vitro condensate reconstitution assay, live-cell imaging, co-immunoprecipitation, genetic manipulation of TorsinA\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution of condensate modulation, live-cell imaging, chaperone network identification with multiple orthogonal methods\",\n      \"pmids\": [\"36302970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MLF2 is phosphorylated at serine 24 (detected by Phos-tag SDS-PAGE), and this phosphorylation is required for MLF2 oncogenic activity in CML; point mutation at Ser24 abolishes the effects of MLF2 overexpression on colony formation in vitro and mouse survival in vivo.\",\n      \"method\": \"Phos-tag SDS-PAGE, site-directed mutagenesis, colony formation assay, mouse xenograft survival\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — phosphorylation confirmed biochemically plus mutagenesis with functional rescue in vitro and in vivo, single lab\",\n      \"pmids\": [\"31831854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MLF2 interacts with both p53 and USP7; via these interactions, MLF2 inhibits USP7 binding to p53 and antagonizes USP7-mediated deubiquitination of p53, leading to p53 destabilization and promoting colorectal carcinogenesis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, loss-of-function experiments, in vivo tumor models\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for both partners, deubiquitination assay establishing mechanism, functional rescue, single lab\",\n      \"pmids\": [\"37438558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PIM3 kinase phosphorylates MLF2 at Ser65, which enhances MLF2 stabilization through interaction with the deubiquitinase USP21; independently, the E3 ligase STUB1 ubiquitinates MLF2 at Lys119 and targets it for proteasomal degradation. MLF2 promotes osteosarcoma metastasis by disrupting the interaction between BiP and IRE1α, thereby activating the IRE1α/XBP1-S-MMP9 axis.\",\n      \"method\": \"In vivo CRISPR activation screen, interactome (STUB1 pulldown), co-immunoprecipitation, kinase assay, ubiquitination assay, site-directed mutagenesis, in vivo metastasis models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods: CRISPR screen, interactome, Co-IP, kinase/ubiquitination assays, mutagenesis, and in vivo validation\",\n      \"pmids\": [\"41090348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MLF2 acts as a chaperone that promotes SWI/SNF (BAF) complex assembly and binding to chromatin; rapid degradation of MLF2 reduces chromatin accessibility at sites dependent on high SWI/SNF occupancy.\",\n      \"method\": \"CRISPR KO screen with epigenome editing, rapid protein degradation (degron), ATAC-seq for chromatin accessibility, ChIP-seq\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — CRISPR screen, acute degron depletion with orthogonal chromatin accessibility and SWI/SNF occupancy readouts, multiple methods\",\n      \"pmids\": [\"40447637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MLF2 interacts with αB-crystallin (CryAB) in cardiomyocytes; MLF2 is upregulated in mouse heart failure models and hypertrophic cardiomyocytes, and its overexpression attenuates pro-hypertrophic gene expression.\",\n      \"method\": \"Protein interaction (pulldown/Co-IP), immunofluorescence in mouse DRM models, cardiomyocyte overexpression with gene expression analysis\",\n      \"journal\": \"Journal of cardiovascular development and disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP/pulldown for CryAB interaction, overexpression phenotype without pathway placement, single lab with limited mechanistic detail in abstract\",\n      \"pmids\": [\"41590846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MLF2 functions as a versatile condensate biomarker for nuclear envelope blebs in DYT1 dystonia; a genome-wide CRISPR/Cas9 screen using MLF2-based condensate readout linked condensate accumulation to microcephaly gene ZNF335 (nucleoplasmic condensates) and RNF26 deletion (nuclear envelope condensates phenocopying torsin deficiency).\",\n      \"method\": \"High-content imaging screen with MLF2 as condensate reporter, genome-wide CRISPR/Cas9 screen, machine learning condensate phenotyping\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide genetic screen with imaging readout using MLF2 as validated reporter, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.07.658469\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MLF2 is a ubiquitously expressed chaperone-like protein that functions at the nuclear envelope to modulate nuclear pore complex biogenesis (as a luminal bleb component dependent on POM121), suppresses FG-nucleoporin condensate formation and modulates HSP40-HSP70 chaperone networks, promotes SWI/SNF chromatin remodeling complex assembly, and is regulated post-translationally by competing ubiquitination (STUB1 at Lys119, CRL4DCAF8) and deubiquitination (USP11, USP21) as well as by phosphorylation (PIM3 at Ser65, at Ser24 in CML); in cancer contexts MLF2 destabilizes p53 by antagonizing USP7-mediated deubiquitination, activates the IRE1α/XBP1-S-MMP9 axis to promote metastasis, and affects nitric oxide synthase signaling in breast cancer stem cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MLF2 is a ubiquitously expressed chaperone-like protein that operates at the nuclear envelope and within chromatin to regulate protein and nucleoporin homeostasis, and that is co-opted in multiple cancers [#0, #4, #10]. At the nuclear envelope, MLF2 is a luminal component of aberrant nuclear envelope blebs that form upon Torsin ATPase manipulation; bleb biogenesis requires the transmembrane nucleoporin POM121 and occurs as cells reassemble nuclear pore complexes after mitosis, marking blebs as defective NPC intermediates [#4]. Within these blebs MLF2 suppresses ectopic FG-nucleoporin accumulation, modulates the selective properties and size of FG-nucleoporin condensates in vitro, and tunes a sequestered HSP40-HSP70 chaperone network that drives proteotoxicity in DYT1 dystonia [#6]. Beyond the envelope, MLF2 acts as a chaperone promoting SWI/SNF (BAF) complex assembly and chromatin binding, such that its acute depletion reduces chromatin accessibility at SWI/SNF-dependent sites [#10]. MLF2 protein levels are set by competing ubiquitination and deubiquitination: the CRL4-DCAF8 E3 ligase and STUB1 (ubiquitinating Lys119) drive proteasomal degradation, while USP11 and USP21 stabilize the protein, and PIM3-mediated phosphorylation at Ser65 promotes stabilization through USP21 [#5, #9]. In cancer, MLF2 destabilizes p53 by blocking USP7-mediated deubiquitination to drive colorectal carcinogenesis [#8], promotes osteosarcoma metastasis by disrupting the BiP-IRE1\\u03b1 interaction to activate the IRE1\\u03b1/XBP1-S-MMP9 axis [#9], and requires Ser24 phosphorylation for its oncogenic activity in CML [#7]. Consistent with its chaperone-like role in protein aggregation, MLF2 is sequestered into poly-GA inclusions in C9orf72 ALS/FTD and preferentially engages mutant polyQ huntingtin, where it increases aggregate mobility and reduces aggregate-induced apoptosis [#1, #2].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established MLF2 as a gene and protein in its own right, a ubiquitously expressed homolog of MLF1, defining the molecular entity before any function was known.\",\n      \"evidence\": \"cDNA cloning, FISH chromosomal mapping, and Southern blotting\",\n      \"pmids\": [\"8661158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No biochemical activity or interaction partner defined\", \"No subcellular localization established\", \"Functional role entirely unknown at this stage\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"First functional implication: MLF2 supports breast cancer growth, metastasis, and cancer stem cell self-renewal, linking it to nitric oxide synthase signaling and hypoxia.\",\n      \"evidence\": \"shRNA/siRNA knockdown in patient-derived xenografts with RNA deep sequencing\",\n      \"pmids\": [\"24876273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct molecular mechanism connecting MLF2 to the NOS pathway\", \"No physical partners identified\", \"Phenotype correlative rather than mechanistic\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated MLF2 in neurodegenerative aggregate biology by showing it is sequestered into pathological protein inclusions, hinting at a chaperone-like or aggregate-engaging activity.\",\n      \"evidence\": \"Co-IP, FRAP and viability assays with polyQ huntingtin in Neuro2A cells; immunofluorescence co-localization with poly-GA inclusions in mouse and ALS/FTD patient tissue\",\n      \"pmids\": [\"27840155\", \"28409281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted binding to demonstrate direct interaction with aggregating species\", \"Mechanism of preferential mutant-HTT engagement undefined\", \"Sequestration into poly-GA shown only by co-localization\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined MLF2 as a luminal nuclear-envelope-bleb component dependent on POM121, recasting blebs as aberrant NPC biogenesis intermediates and giving MLF2 a concrete nuclear-envelope role.\",\n      \"evidence\": \"Proteomics, live-cell imaging with an MLF2-based platform, immunofluorescence, and POM121 genetic depletion\",\n      \"pmids\": [\"32342107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular activity of MLF2 within the bleb not yet defined\", \"How MLF2 is recruited to the luminal space unknown\", \"Functional consequence for mature NPCs not directly tied to MLF2\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed MLF2 abundance is post-translationally controlled by opposing ubiquitin machinery, identifying CRL4-DCAF8 as a destabilizer and USP11 as a stabilizer.\",\n      \"evidence\": \"Reciprocal Co-IP, proteasome inhibitor assays, and overexpression/knockdown\",\n      \"pmids\": [\"32703400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ubiquitination site not mapped in this study\", \"No physiological trigger for degradation defined\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Assigned a biochemical function to MLF2 at the envelope: suppression of FG-nucleoporin condensate accumulation and modulation of a bleb-sequestered HSP40-HSP70 chaperone network underlying DYT1 dystonia proteotoxicity.\",\n      \"evidence\": \"In vitro condensate reconstitution, live-cell imaging, Co-IP, and TorsinA genetic manipulation\",\n      \"pmids\": [\"36302970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding determinants for FG-nucleoporins not mapped\", \"Which HSP40/HSP70 members are engaged and how is incomplete\", \"Stoichiometry and structural basis of condensate modulation unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified phosphorylation at Ser24 as functionally required for MLF2 oncogenic activity in CML, linking a post-translational mark to transforming function.\",\n      \"evidence\": \"Phos-tag SDS-PAGE, Ser24 mutagenesis, colony formation, and mouse xenograft survival\",\n      \"pmids\": [\"31831854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible for Ser24 phosphorylation not identified\", \"Downstream effectors of phospho-MLF2 in CML undefined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established a tumor-promoting mechanism: MLF2 destabilizes p53 by competing with USP7, blocking p53 deubiquitination to drive colorectal carcinogenesis.\",\n      \"evidence\": \"Co-IP with p53 and USP7, ubiquitination assay, loss-of-function, and in vivo tumor models\",\n      \"pmids\": [\"37438558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of MLF2-USP7 competition unresolved\", \"Whether this axis operates in other tumor types untested here\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Integrated MLF2 regulation and a metastasis mechanism: PIM3-Ser65 phosphorylation stabilizes MLF2 via USP21 while STUB1 ubiquitinates Lys119 for degradation, and MLF2 disrupts BiP-IRE1\\u03b1 to activate the IRE1\\u03b1/XBP1-S-MMP9 axis driving osteosarcoma metastasis.\",\n      \"evidence\": \"In vivo CRISPR activation screen, interactome, Co-IP, kinase and ubiquitination assays, site-directed mutagenesis, and in vivo metastasis models\",\n      \"pmids\": [\"41090348\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation at Ser65 mechanistically favors USP21 over STUB1 unclear\", \"Direct binding interface with BiP/IRE1\\u03b1 not structurally defined\", \"Whether the same regulatory logic applies outside osteosarcoma untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealed a chromatin function: MLF2 acts as a chaperone promoting SWI/SNF (BAF) complex assembly and chromatin engagement, with acute loss reducing accessibility at SWI/SNF-dependent sites.\",\n      \"evidence\": \"CRISPR KO screen with epigenome editing, degron-based rapid depletion, ATAC-seq, and ChIP-seq\",\n      \"pmids\": [\"40447637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which BAF subunits MLF2 directly chaperones not specified\", \"Whether nuclear-envelope and chromatin roles are mechanistically linked unknown\", \"Structural basis of chaperone activity undefined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended MLF2 condensate biology by using it as a genome-wide screening reporter, linking nuclear envelope and nucleoplasmic condensate accumulation to ZNF335 and RNF26.\",\n      \"evidence\": \"High-content imaging genome-wide CRISPR/Cas9 screen with MLF2 condensate reporter and machine-learning phenotyping (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.06.07.658469\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not yet peer-reviewed\", \"Mechanistic role of ZNF335/RNF26 relative to MLF2 not established\", \"MLF2's own activity in these condensates not directly tested here\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Suggested a cardiac role through interaction with \\u03b1B-crystallin and an anti-hypertrophic effect on cardiomyocyte gene expression.\",\n      \"evidence\": \"Pulldown/Co-IP for CryAB, immunofluorescence in mouse DRM models, cardiomyocyte overexpression\",\n      \"pmids\": [\"41590846\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single Co-IP/pulldown without reciprocal or structural validation\", \"No pathway placement for the anti-hypertrophic effect\", \"Causality versus correlation in heart failure models unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether MLF2's distinct activities \\u2014 nuclear-envelope condensate modulation, SWI/SNF chaperoning, and oncogenic ubiquitin/IRE1\\u03b1 signaling \\u2014 reflect a single unifying chaperone-like biochemical mechanism remains unresolved.\",\n      \"evidence\": \"No single study reconciles the nuclear-envelope, chromatin, and cancer-signaling roles into one molecular activity\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of MLF2 or its complexes\", \"Core biochemical activity not defined\", \"Tissue-specific selection among partners unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [6, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [5, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 8, 9]}\n    ],\n    \"complexes\": [\"nuclear envelope bleb (aberrant NPC intermediate)\", \"SWI/SNF (BAF) complex (assembly chaperone)\"],\n    \"partners\": [\"POM121\", \"USP11\", \"DCAF8\", \"USP7\", \"STUB1\", \"USP21\", \"PIM3\", \"CryAB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":7,"faith_total":7,"faith_pct":100.0}}